Human p32: A coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication

Virology

Volumn 275, Issue 1, 2000, Pages 145-157

  Van Scoy, Sarah ^a   Watakabe, Ikuko ^a,b,c   Krainer, Adrian R ^a,b   Hearing, Janet ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b Simons Center for Quantitative Biology   (United States)

^c NATIONAL INSTITUTE FOR BASIC BIOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; PROTEIN P32; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA REPLICATION; EPSTEIN BARR VIRUS; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENETIC LINKAGE; HUMAN; HUMAN CELL; LATENT PERIOD; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REPORTER GENE; TRANSCRIPTION REGULATION;

ANIMALIA; DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0034665224     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0508     Document Type: Article

References (66)

1. Replication of latent Epstein-Barr virus genomes in Raji cells
2. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element
3. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1
4. Using the two-hybrid system to detect protein-protein interactions
5. The herpes simplex virus 1 origin binding protein: A DNA helicase
6. Transcriptional activator nuclear factor I stimulates the replication of SV40 minichromosomes in vivo and in vitro
7. Regulation of DNA replication in vitro by the transcriptional activation domain of GAL4-VP16
8. A novel genetic system to detect protein-protein interactions
9. Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus
10. Overproduction, purification and characterization of EBNA1, the origin binding protein of Epstein-Barr virus
11. EBNA1 distorts oriP, the Epstein-Barr virus latent replication origin
12. Rac 'insert region' is a novel effector region that is implicated in the activation of NADPH oxidase, but not PAK65
13. The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication
14. Isolation, cDNA cloning and overexpression of a 33-kD cell surface glycoprotein that binds to the globular 'heads' of C1q
15. Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1), Immunologic detection of EBNA1 in the malignant cells of Hodgkin's disease
16. Two Epstein-Barr viral nuclear neoantigens distinguished by gene transfer, serology and chromosome binding
17. Eukaryotic proteins expressed in Escherichia coli: An improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase
18. Random association of Epstein-Barr virus genomes with host cell metaphase chromosomes in Burkitt's lymphoma-derived cell lines
19. Sequence requirements of the Epstein-Barr virus latent origin of DNA replication
20. The transactivator proteins VP16 and GAL4 bind replication factor A
21. Interaction of the Epstein-Barr virus nuclear antigen 1 with the viral latent origin of replication
22. Eggs: Conveniently packaged antibodies. Methods for purification of yolk IgG
23. Crystal structure of human p32, a doughnut-shaped acidic mitochondrial matrix protein
24. Functional expression of cloned human splicing factor SF2: Homology to RNA-binding proteins, U1 70K and Drosophila splicing regulators
25. Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations
26. Identification of Epstein-Barr virus nuclear antigen 1 protein domains that direct interactions at a distance between DNA-bound protein
27. The acidic transcriptional activation domains of VP16 and p53 bind the cellular replication protein A and stimulate in vitro BPV-1 DNA replication
28. Acidic transcription factors alleviate nucleosome-mediated repression of DNA replication of bovine papillomavirus type 1
29. Activation of chromosomal DNA replication in Saccharomyces cerevisiae by acidic transcriptional activation domains
30. Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line
31. Cellular protein modulates effects of human immunodeficiency virus type 1
32. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells
33. Multiple regions within EBNA1 can link DNAs
34. The linking regions of EBNA1 are essential for its support of replication and transcription
35. Mapping EBNA-1 domains involved in binding to metaphase chromosomes
36. Adenovirus core protein V interacts with p32 - A protein which is associated with both the mitochondria and the nucleus
37. Immunological analysis of yeast chromatin
38. A chimera of EBNA1 and the estrogen receptor activates transcription but not replication
39. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell
40. p32 protein, a splicing factor 2-associated protein, is localized in mitochondrial matrix and is functionally important in maintaining oxidative phosphorylation
41. The adenovirus E4-E6 /7 protein transactivates the E2 promoter by inducing dimerization of a heteromeric E2F complex
42. Analysis of chromatin structure by in vivo formaldehyde crosslinking
43. Inhibition of specific binding of EBNA 1 to DNA by murine monoclonal and certain human polyclonal antibodies
44. A β-galactosidase expression vector for promoter analysis
45. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation
46. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components
47. Epstein-Barr virus
48. Structure and function in the herpes simplex virus 1 RNA-binding protein Us11: Mapping of the domain required for ribosomal and nucleolar association and RNA binding in vitro
49. Adenovirus DNA packaging
50. Mam33p, an oligomeric, acidic protein in the mitochondrial matrix of Saccharomyces cerevisiae is related to the human complement receptor gC1q-R
51. Identification of minimal oriP of Epstein-Barr virus required for DNA replication
52. EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance
53. DNA helicase activity of SV40 large tumor antigen
54. DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site. Stabilization of an origin complex with Epstein-Barr nuclear antigen 1
55. In vitro interaction between human immunodeficiency virus type 1 Rev protein and splicing factor ASF/SF2-associated protein, p32
56. Direct repeats as selective response elements for the thyroid hormone, retinoic acid and vitamin D3 receptors
57. A stretch of 'late' SV40 viral DNA about 400 bp long which includes the origin of replication is specifically exposed in SV40 minichromosomes
58. P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus
59. The E1 protein of the papillomavirus BPV-1 is an ATP-dependent DNA helicase
60. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells
61. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells
62. Dissection of DNA replication and enhancer activation functions of Epstein-Barr virus nuclear antigen 1
63. In vitro interaction of the human immunodeficiency virus type 1 Tat transactivator and the general transcription factor TFIIB with the cellular protein TAP
64. Molecular cloning and characterization of a cellular protein that interacts with the human immunodeficiency virus type 1 tat transactivator and encodes a strong transcriptional activation domain
65. Human RPA (hSSB) interacts with EBNA1, the latent origin binding protein of Epstein-Barr virus